15/05/2026
For years, the stem cell world was stuck in a tradeoff.
You could have a cell that was powerful — pluripotent, able to turn into different tissues, capable of real regeneration. But it came with risk. Tumor formation. Cancer concerns. That’s why a lot of the most promising therapies never made it to patients.
Or you could have a safe cell. Predictable. But limited in what it could actually do.
You couldn’t have both. Until you could.
That’s when I came across the MUSE cell. Discovered by Dr. Mari Dezawa in Japan. A cell that is genuinely pluripotent — but non-tumorigenic. No cancer risk. The biology behind it is elegant, and honestly, ahead of its time.
When I first started using MUSE cells, almost nobody outside of Japan was talking about them. The science was published, but the world hadn’t caught up.
We treated some high profile patients. Chris Hemsworth was one of the first to share his experience publicly. Then Kim Kardashian. Suddenly the conversation opened. Awareness grew. And now there’s a company scaling manufacturing to make MUSE cells available globally.
That’s the part I’m most excited about — because for me, it was never about treating a handful of people. It was always about how do we help the most amount of people possible.
Right place, right time. Maybe a little bit of luck. But mostly — asking the right questions, early.
This is just the beginning.